Scarica l'app Stockscreener
13.95
6.90%
0.90
Precedente Chiudi:
$13.05
Aprire:
$13.22
Volume 24 ore:
210.12K
Relative Volume:
1.00
Capitalizzazione di mercato:
$522.30M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-10.00%
1M Prestazione:
-1.97%
6M Prestazione:
+17.52%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$13.06
$14.21
Intervallo di 1 settimana:
$12.84
$15.68
Portata 52W:
$5.485
$31.13
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Nome
Oruka Therapeutics Inc
Settore
Industria
Telefono
650-606-7910
Indirizzo
855 OAK GROVE AVE., MENLO PARK
Confronta ORKA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
13.95 | 488.60M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-10-11 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-17 | Iniziato | Leerink Partners | Outperform |
| 2024-09-16 | Iniziato | TD Cowen | Buy |
| 2024-09-13 | Iniziato | Jefferies | Buy |
| 2018-02-27 | Iniziato | Ascendiant Capital Markets | Buy |
| 2013-10-09 | Iniziato | Dawson James | Buy |
Mostra tutto
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
Oruka Therapeutics’ (ORKA) Outperform Rating Reaffirmed at Wedbush - Defense World
What Fibonacci levels say about Oruka Therapeutics Inc. reboundFree Chart Breakout Buy Signal Detection - Newser
What makes Oruka Therapeutics Inc. stock price move sharplyMarket Timing Strategy with Technical Filters - Newser
Oruka Therapeutics stock maintains Buy rating at BTIG on promising psoriasis treatments - Investing.com Canada
Why Oruka Therapeutics Inc. stock attracts strong analyst attentionStock Entry Point Planner with Volume Spike - Newser
Oruka Therapeutics Reports Q2 2025 Financial Results - TipRanks
How high can Oruka Therapeutics Inc. stock price go in 2025Free Entry Alert Based on Volume Spikes - Newser
Custom watchlist performance reports with Oruka Therapeutics Inc.Algorithmic Prediction of Market Breakouts - Newser
Oruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial - MSN
Oruka's Novel Psoriasis Drug Enters Phase 2a: Potential Yearly Dosing Could Transform Treatment Landscape - Stock Titan
Smart tools for monitoring Oruka Therapeutics Inc.’s price actionFree Entry Points For Growing Stocks - Newser
Long term hold vs stop loss in Oruka Therapeutics Inc.Daily Pick Forecast with Entry Zones - Newser
Has Oruka Therapeutics Inc. found a price floorCapital Growth Summary Over Five Years - Newser
Published on: 2025-08-10 17:56:29 - beatles.ru
RSI + MACD Show Convergence for Oruka Therapeutics Inc.Reliable Alerts for Daily Stock Movers Released - metal.it
How to build a custom watchlist for Oruka Therapeutics Inc.Buy Strategy with Smart Exit Timing - Newser
Published on: 2025-08-10 12:04:33 - metal.it
Oruka Therapeutics Inc. Inches Above Key Support — Safe to HoldLow Risk High Return Opportunities Identified - metal.it
How Oruka Therapeutics Inc. stock performs during market volatilityFree Early Entry Tips With Low Risk Zone - Newser
Technical analysis overview for Oruka Therapeutics Inc. stockFree Breakout Momentum Picks With Protection - Newser
Published on: 2025-08-09 01:24:57 - Newser
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Recommendation of “Buy” from Analysts - Defense World
How to integrate Oruka Therapeutics Inc. into portfolio analysis toolsEarnings Report Summary with Market Impact - Newser
Can technical indicators confirm Oruka Therapeutics Inc.’s reversalWeekly Movement Forecast With Chart Signals - Newser
Oruka Therapeutics (ORKA) Expected to Announce Earnings on Thursday - Defense World
Oruka Therapeutics Inc. Earnings Report Breakdown: What Investors Should KnowFree Breakout Entry Signal Confirmation Tool - Newser
What data driven models say about Oruka Therapeutics Inc.’s futureMinimal Risk Growth Investment Opportunity Analysis - Newser
TD Cowen Maintains Oruka Therapeutics(ORKA.US) With Buy Rating - 富途牛牛
Is Oruka Therapeutics Inc. a good long term investmentFree Stock Selection - Jammu Links News
How strong is Oruka Therapeutics Inc. company’s balance sheetSky-high profits - Jammu Links News
How does Oruka Therapeutics Inc. generate profit in a changing economyIdentify winners with top-tier analysis - Jammu Links News
Is it the right time to buy Oruka Therapeutics Inc. stockAchieve triple-digit returns with smart investing - Jammu Links News
Why is Oruka Therapeutics Inc. stock attracting strong analyst attentionBuild a portfolio that grows with the market - Jammu Links News
What are the latest earnings results for Oruka Therapeutics Inc.Free Stock Market Beginners Guide - Jammu Links News
Is Oruka Therapeutics Inc. stock overvalued or undervaluedBuild a diversified portfolio for sustainable growth - Jammu Links News
How volatile is Oruka Therapeutics Inc. stock compared to the marketDiscover undervalued stocks ready to soar - Jammu Links News
What is Oruka Therapeutics Inc. company’s growth strategyUnlock steady growth with low-risk stocks - Jammu Links News
What are Oruka Therapeutics Inc. company’s key revenue driversConsistently exceptional gains - Jammu Links News
Oruka Therapeutics Inc Azioni (ORKA) Dati Finanziari
Non sono disponibili dati finanziari per Oruka Therapeutics Inc (ORKA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):